Idorsia GAAP EPS of -0.06 CHF, revenue of 72M CHF
Source: SeekingAlpha
2025-07-30 10:46:59 ET
More on Idorsia
Read the full article on Seeking Alpha
For further details see:
Idorsia GAAP EPS of -0.06 CHF, revenue of 72M CHF
Idorsia Ltd Registered Shares
NASDAQ: IDRSF
IDRSF Trading
0.0% G/L:
$5.16 Last:
1,502 Volume:
$5.16 Open:
IDRSF Latest News
January 05, 2026 11:45:00 am
Idorsia's daridorexant in women during menopausal transition age with insomnia
December 10, 2025 01:00:00 am
New Hypertension publication underscores aprocitentan's potential in managing hypertension patients with CKD
November 10, 2025 11:45:00 am
Idorsia's aprocitentan improved key prognostic indicators in patients with difficult-to-control hypertension
November 05, 2025 11:45:00 am
Idorsia to present new aprocitentan insights at ASN Kidney Week & AHA Scientific Sessions
